GSK's clinical-stage pipeline is currently focused on oncology, respiratory, immunology and inflammation, and infectious ...

Medical affairs is evolving. Once primarily viewed as a support function in healthcare, it now plays a central role in bridging the gap between research and clinical application. Today's medical ...

UK biotech Epsilogen has bought US-based TigaTx, pooling their resources to create what it says will be a leader in 'pan-isotope' cancer antibodies. Epsilogen rose to prominence a few years ago by ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's ...

A proposal by the Biden administration to cover weight-loss medicines for obesity under Medicare has been axed by the White ...

Declining measles vaccination isn't a problem confined to the US. Last month, the World Health Organization (WHO) and UNICEF ...

Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

“If I had asked people what they wanted, they would have said faster horses.” This quote, often linked to Henry Ford (though its authenticity is debated), has become a go-to argument for ...

On 11th February, pharmaphorum was invited by Curia to attend a parliamentary roundtable focussed on women’s health, held at the House of Commons and hosted in collaboration with Members of ...

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to discuss integrated evidence plans, data sharing optimization ...

The study compared CGM to regular fingerprick testing on blood glucose readings after consuming commercial or home-made smoothies or a glucose drink as a control. There has been a major increase ...